je.st
news
Tag: priority
Electric cars set to get road priority in clean air zones
2016-10-14 14:06:05| BBC News | Business | UK Edition
Electric cars could be given priority at traffic lights and exempted from one-way systems, a government consultation suggests.
MAKE FERTILITY TOP PRIORITY IN REPLACEMENT FEMALES
2016-10-10 22:09:03| Cattle Today
It's no secret that replacement heifers are some of the most valuable animals in your herd; however, value goes hand in hand with vulnerability. With recent record-high costs to develop replacement females, it may be time to consider a refresh on your replacement heifer program.
Tags: top
make
priority
replacement
TPP pork producers top priority during fly-in
2016-09-16 21:09:00| National Hog Farmer
Source: National Pork Producers Council Getting a vote this year on the Trans-Pacific Partnership agreement was the top issue on which pork producers from around the country lobbied their congressional lawmakers this week. read more
Tags: top
priority
producers
pork
Efficient Drivetrains and First Priority Greenfleet partner to produce commercial plug-in vehicles for fleets
2016-09-08 19:55:25| Green Car Congress
Tags: for
partner
commercial
produce
FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants Breakthrough Therapy Designation to Mercks KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
2016-09-07 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Merck Has Also Submitted a Marketing Authorization Application to the European Medicines Agency for KEYTRUDA in the Same Patient Population Submissions Based on Data from KEYNOTE-024 Trial Showing Superior Progression-Free and Overall Survival Compared to Chemotherapy in Patients Whose Tumors Express High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors express PD-L1, with a PDUFA, or target action, date of Dec. 24, 2016. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
review
application
license
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »